Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CES1 | P23141 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.32 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4457743 | 0.81 | KMT2A (0.38) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL86001 | 0.79 | ATM (0.41) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL4456724 | 0.79 | ATM (0.41) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL8144898 | 0.78 | ATM (0.43) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL6065230 | 0.78 | ATM (0.36) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL8675243 | 0.76 | ATM (0.39) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL20875962 | 0.75 | ATM (0.41) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL85970 | 0.73 | ATM (0.49) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL22930710 | 0.72 | ATM (0.44) | ATMKMT2ANPC1GPR35ALDH1A1 | |
| SCHEMBL15827671 | 0.71 | ATM (0.41) | ATMKMT2ANPC1GPR35ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3911687-B1 | LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING | BASF SE (DE) | 2023-11-01 | — | — | EP | disclosed |
| US-20230241675-A1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| US-20230241675-A1 | COMPOSITIONS, COMPRISING PLATELET-SHAPED TRANSITION METAL PARTICLES | BASF SE (DE) | 2023-08-03 | — | — | US | disclosed |
| WO-2023072740-A1 | A METHOD FOR PRODUCING INTERFERENCE ELEMENTS | BASF SE (DE) | 2023-05-04 | — | — | WO | disclosed |
| EP-3914458-B1 | SECURITY ELEMENT | BASF SE (DE) | 2022-12-21 | — | — | EP | disclosed |
| US-20220220284-A1 | COMPOSITIONS, COMPRISING SILVER NANOPLATELETS | BASF SE (DE) | 2022-07-14 | — | — | US | disclosed |
| US-20220064350-A1 | LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING | BASF SE (DE) | 2022-03-03 | — | — | US | disclosed |
| US-20220033678-A1 | PHOTOCURABLE COMPOSITION FOR USE IN 3D PRINTING | BASF SE (DE) | 2022-02-03 | — | — | US | disclosed |
| US-20210402466-A1 | COMPOSITIONS, COMPRISING SILVER NANOPLATELETS | BASF SE (DE) | 2021-12-30 | — | — | US | disclosed |
| US-20210395558-A1 | UV CURABLE COMPOSITION FOR USE IN 3D PRINTING | BASF SE (DE) | 2021-12-23 | — | — | US | disclosed |
| US-8128804-B2 | Process for stabilizing olefinically unsaturated monomers | EVONIK DEGUSSA GMBH (DE) | 2012-03-06 | — | — | US | disclosed |
| US-20110319535-A1 | IN-CAN STABILIZERS | NESVADBA PETER (CH) | 2011-12-29 | — | — | US | disclosed |
| US-20110319535-A1 | IN-CAN STABILIZERS | NESVADBA PETER (CH) | 2011-12-29 | — | — | US | disclosed |
| US-7651635-B1 | Polymer inhibition of vinyl aromatic monomers using a quinone methide/alkyl hydroxylamine combination | NALCO COMPANY (US) | 2010-01-26 | — | — | US | disclosed |
| US-7651635-B1 | Polymer inhibition of vinyl aromatic monomers using a quinone methide/alkyl hydroxylamine combination | NALCO COMPANY (US) | 2010-01-26 | — | — | US | disclosed |
| US-20090114878-A1 | PROCESS FOR STABILIZING OLEFINICALLY UNSATURATED MONOMERS | EVONIK DEGUSSA GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| US-20090114878-A1 | PROCESS FOR STABILIZING OLEFINICALLY UNSATURATED MONOMERS | EVONIK DEGUSSA GMBH (DE) | 2009-05-07 | — | — | US | disclosed |
| EP-1873199-A1 | In-can stabilizers | Ciba Specialty Chemicals Holding Inc. (CH) | 2008-01-02 | — | — | EP | disclosed |
| US-20070225397-A1 | In-Can Stabilizers | CIBA SPECIALTY CHEMICALS CORP. | 2007-09-27 | — | — | US | disclosed |
| US-20070225397-A1 | In-Can Stabilizers | CIBA SPECIALTY CHEMICALS CORP. | 2007-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220064350-A1 | LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING | LIMK1, LIMA1, LIMK2 | ATM 110/4885KMT2A 742/4885NPC1 4851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.